日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

STAMBPL1 activates the GRHL3/HIF1A/VEGFA axis through interaction with FOXO1 to promote angiogenesis in triple-negative breast cancer.

STAMBPL1 通过与 FOXO1 相互作用激活 GRHL3/HIF1A/VEGFA 轴，从而促进三阴性乳腺癌的血管生成

期刊:Elife
影响因子:6.4
doi:10.7554/eLife.102433
Fang Huan, Liang Huichun, Yang Chuanyu, Jiang Dewei, Luo Qianmei, Cao Wen-Ming, Zhang Huifeng, Chen Ceshi
肿瘤
乳腺癌
Angiogenesis
血管生成
发表日期：2025
文献求助 收藏

FOXK2 amplification promotes breast cancer development and chemoresistance.

FOXK2扩增促进乳腺癌发展和化疗耐药性

期刊:Cancer Letters
影响因子:10.1
doi:10.1016/j.canlet.2024.217074
Yu Yang, Cao Wen-Ming, Cheng Feng, Shi Zhongcheng, Han Lili, Yi Jinling, da Silva Edaise M, Dopeso Higinio, Chen Hui, Yang Jianhua, Wang Xiaosong, Zhang Chunchao, Zhang Hong
肿瘤
乳腺癌
肿瘤免疫
发表日期：2024
文献求助 收藏

HR-positive/HER2-negative breast cancer arising in patients with or without BRCA2 mutation: different biological phenotype and similar prognosis

HR阳性/HER2阴性乳腺癌发生于携带或不携带BRCA2突变的患者中：不同的生物学表型和相似的预后

期刊:Therapeutic Advances in Medical Oncology
影响因子:4.2
doi:10.1177/17588359241242613
Li, Pu-Chun; Zhu, Yi-Fan; Pan, Jia-Ni; Zhu, Qiao-Yan; Liao, Yu-Yang; Ding, Xiao-Wen; Zheng, Lin-Feng; Cao, Wen-Ming
肿瘤
HER2
肿瘤免疫
BRCA2
乳腺癌
发表日期：2024
文献求助 收藏

High chromosomal instability is associated with higher 10-year risks of recurrence for hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: clinical evidence from a large-scale, multiple-site, retrospective study

染色体高度不稳定性与激素受体阳性、人表皮生长因子受体2阴性乳腺癌患者10年复发风险增加相关：一项大规模、多中心回顾性研究的临床证据

期刊:Journal of Pathology Clinical Research
影响因子:3.7
doi:10.1002/2056-4538.70011
Liao, Yu-Yang; Fu, Jianfei; Lu, Xiang; Qian, Ziliang; Yu, Yang; Zhu, Liang; Pan, Jia-Ni; Li, Pu-Chun; Zhu, Qiao-Yan; Li, Xiaolin; Sun, Wenyong; Wang, Xiao-Jia; Cao, Wen-Ming
肿瘤
肿瘤免疫
信号转导
乳腺癌
免疫/内分泌
发表日期：2024
文献求助 收藏

AcornHRD: an HRD algorithm highly associated with anthracycline-based neoadjuvant chemotherapy in breast cancer in China

AcornHRD：一种与中国乳腺癌蒽环类新辅助化疗高度相关的HRD算法

期刊:European Journal of Medical Research
影响因子:3.4
doi:10.1186/s40001-024-01936-y
Pan, Jia-Ni; Li, Pu-Chun; Wang, Meng; Li, Ming-Wei; Ding, Xiao-Wen; Zhou, Tao; Wang, Hui-Na; Wang, Yun-Kai; Chen, Li-Bin; Wang, Rong; Ye, Wei-Wu; Wu, Wei-Zhu; Lou, Feng; Wang, Xiao-Jia; Cao, Wen-Ming
肿瘤
肿瘤免疫
乳腺癌
发表日期：2024
文献求助 收藏

Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial

吡咯替尼联合多西他赛作为HER2阳性转移性乳腺癌一线治疗：PANDORA II期试验

期刊:Nature Communications
影响因子:15.7
doi:10.1038/s41467-023-44140-y
Zheng, Yabing; Cao, Wen-Ming; Shao, Xiying; Shi, Yanxia; Cai, Li; Chen, Wenyan; Liu, Jian; Shen, Peng; Chen, Yiding; Wang, Xian; Li, Huiping; Li, Man; Chen, Zhanhong; Wang, Xiaojia
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

The progress in our understanding of CIN in breast cancer research

我们对乳腺癌研究中宫颈上皮内瘤变（CIN）的理解取得了进展

期刊:Frontiers in Oncology
影响因子:3.3
doi:10.3389/fonc.2023.1067735
Liao, Yu-Yang; Cao, Wen-Ming
肿瘤
肿瘤免疫
乳腺癌
发表日期：2023
文献求助 收藏

A comprehensive analysis of Fanconi anemia genes in Chinese patients with high-risk hereditary breast cancer

对中国高危遗传性乳腺癌患者范可尼贫血基因的全面分析

期刊:Journal of Cancer Research and Clinical Oncology
影响因子:2.8
doi:10.1007/s00432-023-05236-6
Zhu, Qiao-Yan; Li, Pu-Chun; Zhu, Yi-Fan; Pan, Jia-Ni; Wang, Rong; Li, Xiao-Lin; Ye, Wei-Wu; Ding, Xiao-Wen; Wang, Xiao-Jia; Cao, Wen-Ming
肿瘤
肿瘤免疫
乳腺癌
代谢
贫血
发表日期：2023
文献求助 收藏

Cardiac Safety in Breast Cancer Patients Receiving Pegylated Liposome Doxorubicin Sequential Anti-HER2 Monoclonal Antibody Therapy

接受聚乙二醇化脂质体阿霉素序贯抗HER2单克隆抗体治疗的乳腺癌患者的心脏安全性

期刊:Frontiers in Pharmacology
影响因子:4.8
doi:10.3389/fphar.2022.883600
Huang, Ping; Huang, Jia-Huan; Zheng, Ya-Bing; Cao, Wen-Ming; Shao, Xi-Ying; Chen, Jun-Qing; Huang, Yuan; Li, Guang-Liang; Sharma, K; Zhou, Huan-Huan; Wang, Xiao-Jia; Jin, Hong-Chuan; Chen, Zhan-Hong
单克隆抗体
乳腺癌
HER2
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏

Comprehensive Analysis of Somatic Reversion Mutations in Homologous Recombination Repair (HRR) Genes in A Large Cohort of Chinese Pan-cancer Patients

对中国泛癌患者大型队列中同源重组修复（HRR）基因体细胞回复突变的综合分析

期刊:Journal of Cancer
影响因子:3.2
doi:10.7150/jca.65650
Zong, Hong; Zhang, Jian; Xu, Zhengyang; Pan, Jia-Ni; Wang, Rong; Han, Jinming; Jiang, Miao; Ren, Ruiping; Zang, Li; Wang, Haitao; Cao, Wen-Ming
细胞生物学
肿瘤
肿瘤免疫
发表日期：2022
文献求助 收藏